InvestorsHub Logo

bme

Followers 37
Posts 2476
Boards Moderated 0
Alias Born 05/16/2007

bme

Re: The Night Stalker post# 592

Saturday, 06/17/2023 6:55:20 PM

Saturday, June 17, 2023 6:55:20 PM

Post# of 608
The next quarter fin should include the rev for TAVALISSE. "In April, Rigel's partner Kissei announced the launch of TAVALISSE in Japan for the treatment of chronic ITP."
1. What else should we expect as for the rev?
2. Result of phase 3 of Fostamatinib3 COVID 19?
3. Status of Fostamatinib-ACTIV4 COVID 19?
4. Partnered Programs?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent RIGL News